Human papillomavirus (HPV) type 18 induces extended growth in primary human cervical, tonsillar, or foreskin keratinocytes more effectively than other high-risk mucosal HPVs.
about
Novel recombinant papillomavirus genomes expressing selectable genes.Human papillomavirus type 16 (HPV-16) genomes integrated in head and neck cancers and in HPV-16-immortalized human keratinocyte clones express chimeric virus-cell mRNAs similar to those found in cervical cancers.Comparison of the miRNA profiles in HPV-positive and HPV-negative tonsillar tumors and a model system of human keratinocyte clones.Longitudinal assessment of DNA methylation changes during HPVE6E7-induced immortalization of primary keratinocytes.Brd4 Activates Early Viral Transcription upon Human Papillomavirus 18 Infection of Primary Keratinocytes.Sp100 provides intrinsic immunity against human papillomavirus infection.Differential in vitro immortalization capacity of eleven (probable) [corrected] high-risk human papillomavirus typesPrognostic significance of non-HPV16 genotypes in oropharyngeal squamous cell carcinoma.Human papillomavirus (HPV)-18 E6 oncoprotein interferes with the epithelial cell polarity Par3 protein.Interferon treatment of human keratinocytes harboring extrachromosomal, persistent HPV-16 plasmid genomes induces de novo viral integration.Prevalence and prognostic value of human papillomavirus genotypes in tonsillar squamous cell carcinoma: a Korean multicenter study.Analyzing the Human Papillomavirus (HPV) Life Cycle in Primary Keratinocytes with a Quantitative Colony-Forming Assay.Chromosome stability in tonsillar squamous cell carcinoma is associated with HPV16 integration and indicates a favorable prognosis.Use of a Rho kinase inhibitor to increase human tonsil keratinocyte longevity for three-dimensional, tissue engineered tonsil epithelium equivalents.
P2860
Q30829946-7B288510-6B32-4BD9-9DC6-E1996C562771Q34529694-154F2DDA-7ECA-43B9-B75C-B8E4E9162768Q36067876-ADF19A60-E8A1-4C98-B5CF-6048A7D0D699Q36212820-373CA9F7-5878-49DD-9986-BF535702622BQ37430517-54616357-8AD8-40F5-A0FD-4A4B50B7E3FBQ37482505-77B15CD9-C219-48AE-80DD-0D8336744375Q37547351-C2CD1058-01BC-4F20-A2D1-3A1BBB2ACAA7Q38816144-CBA91268-52A7-4276-AB7F-AD9EB5626F5EQ39030848-26DA0C78-6684-4F3C-B8AC-03D85637A544Q41652681-135595C7-1180-499D-BF06-5FB910D903F2Q41715844-14C8E10C-445D-4792-A3BB-369486CF38ABQ42220946-442CC34F-08FB-44A1-AEDB-7516C29960C8Q45126102-F7855EE2-668D-4033-BA53-652682A8F666Q47430084-C8838833-B534-4B1F-BCA3-573E365EAA02
P2860
Human papillomavirus (HPV) type 18 induces extended growth in primary human cervical, tonsillar, or foreskin keratinocytes more effectively than other high-risk mucosal HPVs.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Human papillomavirus (HPV) typ ...... other high-risk mucosal HPVs.
@en
Human papillomavirus (HPV) typ ...... other high-risk mucosal HPVs.
@nl
type
label
Human papillomavirus (HPV) typ ...... other high-risk mucosal HPVs.
@en
Human papillomavirus (HPV) typ ...... other high-risk mucosal HPVs.
@nl
prefLabel
Human papillomavirus (HPV) typ ...... other high-risk mucosal HPVs.
@en
Human papillomavirus (HPV) typ ...... other high-risk mucosal HPVs.
@nl
P2093
P2860
P356
P1433
P1476
Human papillomavirus (HPV) typ ...... n other high-risk mucosal HPVs
@en
P2093
Aaron D Bossler
James R Anson
John H Lee
Lubomir P Turek
Michael J Lace
Thomas H Haugen
P2860
P304
11784-11794
P356
10.1128/JVI.01370-09
P407
P577
2009-09-09T00:00:00Z